Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...
After a 2024 in which AbbVie’s Skyrizi boasted the highest TV drug ad spending outlay on seven of our monthly roundups—and took second place in four more—the immunology med has seen that dominance ...
Despite continued uncertainty and mounting regulatory challenges, pharma TV ad spend topped $7 billion through the first 11 months of 2025. Recently released data by iSpot.tv found that the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback